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Abstract 
Arginine-vasopressin has been subjected to a long (11 s) molecular-dynamics simulation in 
aqueous solution. Analysis of the results by DASH and principal components analyses reveals 
four main ring conformations that move essentially independently of the faster-moving tail 
region. Two of these conformations (labeled “saddle”) feature well-defined -turns in the 
ring and conserved transannular hydrogen bonds, whereas the other two (“open”) feature 
neither. The conformations have been identified and defined and are all of sufficient stability 
to be considered candidates for biologically active conformations in in their cognate 
receptors. 
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Introduction 
8-Arginine-vasopressin (AVP, also known simply as vasopressin (VP), antidiuretic hormone 
(ADH) or argipressin), one of the first biologically active peptides to be synthesized by du 
Vigneaud in 19541, is a nonapeptide with a six-membered cyclic moiety (Cys1-Tyr2-Phe3-Gln4-
Asn5-Cys6) closed by a Cys1-Cys6 disulfide bridge, and an -amidated three residue tail (Pro7-
Arg8-Gly9-NH2). 
AVP is a neurohypophyseal hormone and belongs to the vasopressin family of the 
evolutionary lineage vasotocin-vasopressin. Vasopressin-like hormones are found in all 
vertebrates, with AVP being the mammalian form. They all possess a basic amino acid, such 
as arginine or lysine, in position eight and are all involved in water homeostasis (for reviews 
see inter alia2). 
AVP is synthesized in the magnocellular neurons of the posterior pituitary gland3 complexed 
with neurophysin (NP), its carrier protein4. The function of NP is to target, package and store 
AVP before release into the bloodstream2b. The receptors activated by AVP belong to the 
transmembrane G-protein coupled receptor (GPCR) superfamily2a. 
Once secreted into the blood stream, AVP is implicated in myriad physiological functions 
within the endocrine and neurocrine systems. Examples of its hormone function in addition 
to water homeostasis2 include regulation of blood pressure5, antipyretic6 and analgesic 
effects7. AVP acts as secretagogue for adrenocorticotropin2b,8, glucagon and insulin9. The 
peptide is thought to mediate social and sexual behavior, especially aggression, anxiety and 
pair-bonding10. Furthermore, AVP is believed to enhance memory and facilitate learning2b 
and to be involved in the pathophysiology of clinical disorders such as autism11, and may 
even play a role in circadian rhythm misalignments, like jet lag12.  
Lowered AVP release in humans effects an increased blood sodium concentration 
(hypernatremia), excessive urine production (polyuria) and thirst. This may in turn lead to 
diabetes insipidus treatable by administration of AVP and AVP analogs13. In contrast, 
heightened AVP release causes hyponatremia, which may result in brain diseases and lung 
cancer14 and can be treated with AVP-receptor antagonists15. AVP can be used in emergency 
medicine as an alternative to epinephrine in the event of cardiac arrest16.  
Conformation and dynamics of 8-Arg-vasopressin in solution (accepted author manuscript/ post-print) 
3 
 
To date, the only fully resolved crystal structure of AVP is as part of a trypsin complex (PDB 
ID: 1YF4)17. This structure contains a remarkably different backbone conformation to those 
found for the closely related peptide hormones 8-Lys-vasopressin (LVP, PDB ID: 1JK44) and 
oxytocin (OT, PDB ID: 1NPO18) in their NP-complexes in the solid state. 
The conformational characteristics of the peptide structures in the physiologically relevant 
neurophysin-complexes are a saddle-like ring with -turns involving residues 3,4/4,5 and a 
high occurrence of transannular hydrogen bonds, primarily between Tyr2O and Asn5NH (cf. 
Scheme 1b). The tripeptide tail is only resolved in the OT-NP complex (PDB ID: 1NPO) where 
it is folded and possibly stabilized by a hydrogen bond Cys6O-Gly9NH (cf. Scheme 2b).  
NMR studies suggest rapid interchange between the β-turn conformations of AVP in 
solution, although a folded (saddle) geometry appears to be maintained19. The polarity of 
the solvent seems only to affect formation of intramolecular hydrogen bonds. In DMSO, a 
hydrogen bond is indicated between Tyr2O and Asn5NH 19 but apparently not in water20. 
Studies in SDS micelles suggest the hydrophilic regions of the ring interact with a membrane, 
while the hydrophobic tail is exposed to the aqueous phase. Again, in this study the cyclic 
backbone of the AVP ring attached to the micelles appears similar to the NP-complexed 
form21.  
These saddle-like conformations with a strongly puckered ring and the β-turns mentioned 
above have been confirmed computationally as “low-energy conformations” inter alia by 
Liwo et al.22 via Monte Carlo and molecular-dynamics simulations.  
In contrast, the conformation of AVP within the trypsin complex (PDB ID: 1YF4) is 
characterized by an unfolded, more planar ring conformation, here designated as “open”, 
with no significant internal hydrogen bonds and an extended tail (cf. Scheme 1a). AVP is an 
efficient inhibitor of trypsin17, although this is not known to be a true physiological function 
of AVP. The open conformation adopted in this trypsin complex can nevertheless be 
regarded as a bioactive conformation. 
To our knowledge, little attention has been paid to an open conformation or its potential 
role in receptor binding with the vasopressin-receptor V2R23.  
The V2R agonist-binding-pocket, common to all VP and OT receptor types, is located in a 
cleft within the transmembrane (TM) domains and AVP has been proposed to be almost 
completely buried within the receptor channel23,24. The hydrophobic ring-residues (Cys1-Tyr2-
Phe3) are predicted to interact with residues of the TM-helices to activate signal 
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transduction, while the tail points outside the TM-core, interacting with an extracellular loop 
via its hydrophilic residue Arg8. The interaction between Arg8 and the extracellular loops is 
also thought to be a key in receptor recognition2a,25.  
Current models for interactions of peptide hormones with their receptors suggest multi-step 
mechanisms in which the peptide first contacts the cell membrane and then diffuses to the 
receptor until it finally finds its position to trigger receptor activities26. These events are 
probably accompanied by conformational changes of the ligand and concomitant allosteric 
effects on the receptors27. A flexible ligand exists in solution as an equilibrium involving 
several conformations of differing bioactivities. A conformation that has not yet been 
recognized with “slow” experimental techniques, such as NMR, might nevertheless be the 
important conformation for triggering biological effects such as receptor recognition and 
activation or inhibition27,28. 
Thus, we have now investigated the conformational dynamics of this peptide in solution in 
depth with modern computational methods and analysis tools with special regard to the 
open conformation, which is evident in the largely ignored 1YF4 X-ray structure of AVP and is 
significantly different from the known saddle conformation.  
Molecular-dynamics (MD) simulations have proven to be an accurate tool for describing the 
atomistic details of the conformational dynamics of biological systems in solution (e.g.29). 
Rapidly developing computational methods, increasing computational performance and 
improved force fields now make it possible to reveal new structural aspects of systems such 
as AVP, especially because microsecond simulations are now possible for a peptide of this 
size. 
We now report an unrestrained 11 µs MD simulation of the AVP-1YF4-peptide in explicit 
water solvent at 300 K using AMBER 1030 and a detailed analysis of the resulting 
conformational space with several analysis tools contained in Ptraj31 and DASH32, a fast 
conformational analysis tool for MD simulations developed especially for long trajectories 
for which classical clustering algorithms scale poorly.  
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Methods 
Molecular dynamics simulation 
The AMBER10 program suite30 was used to optimize geometries and for the MD simulations. 
The X-ray structure of AVP from the trypsin complex (PDB ID: 1YF4)17 was chosen as the 
initial conformation. The peptide was placed in a truncated octahedron water box (box size 
(XYZ) = 38.97 Å3) using the TIP4P-Ew water model33. Two chloride counterions were added to 
neutralize the system. The simulation system consisted of a total of 4,792 atoms, including 
1,162 4-site water molecules and 142 AVP atoms. 
The system was optimized using 500 steps of steepest-descent optimization followed by 
8,945 of conjugated-gradient minimization at constant volume. 
Molecular dynamics simulations were carried out using the AMBER ff99SB force field34 under 
constant temperature (T = 300 K, Berendsen coupling35 of 1.0 ps to an external heat bath) 
and constant pressure (p = 1 atm) periodic boundary conditions with a non-bonded cut off of 
8 Å. The SHAKE36 algorithm was employed for hydrogen atoms with a simulation time step of 
2 fs. Energies were calculated using the Particle Mesh Ewald method37 and coordinate 
'snapshots' were written every picosecond. AVP was simulated in explicit water at 300 K for 
11 µs.  
DASH analysis 
Conformational clustering was performed with DASH, Version 2.10.32 DASH is a fast 
conformational analysis tool for MD simulations developed especially for long trajectories 
for which classical pairwise distance-metric clustering algorithms (Cα) scale poorly. It 
analyses time-series of torsion angles, e.g. the trajectories of the Φ/Ψ dihedral angles of the 
protein/peptide backbone during the MD simulation. The result is a time series of DASH 
states called a DASH state trajectory. A DASH state is simply an ensemble of torsion angles 
that is representative for a main conformation (equivalent to a conformational cluster). No 
predetermined number of states is required, in contrast to clustering algorithms that use a 
similarity matrix, such as those implemented in AMBER tools31. A conformation must persist 
for a minimum number of time steps before it is identified as a DASH state, which gives an 
accurate representation of significant conformational changes. The DASH software is 
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released under the terms of the GNU General Public License and can be downloaded from 
the University of Portsmouth website38.  
Principal component analysis 
The principal component (PC) analysis (PCA) was conducted using the dihedral angles 
extracted from the simulation (11,000 snapshots) using SAR-caddle39. Kaiser’s eigenvalue-
one test40 was used to determine the number of significant PCs. Weights are simply the 
squares of the coefficients of the torsional angles in the relevant PC.  
 
Further details of the calculations and analyses are given in the Supporting Information. 
Results and discussion 
Ring conformations 
Trajectory (transitions) 
An 11 µs MD simulation of AVP in solution reveal the high conformational flexibility and 
fluctuation of this peptide (see Video S 1). Figure 1a shows the trajectory of conformational 
changes of the Cα-backbone atoms 1 to 9 of AVP as root mean square deviation (RMSD) 
from the minimized starting conformation (PDB ID: 1YF4). Average RMSD values of distinct 
time-windows from the trajectory are given in Table 1. Significant RMSD changes indicate 
significant conformational changes, but despite a high fluctuation, there are only few 
substantial RMSD changes during the 11 µs MD simulation. The most obvious transition is at 
1.46 µs. Limiting the RMSD calculation either to the ring (Fig. 1b) or to the tail Cα-atoms 
(Fig. 1d) shows that the major overall transition of the peptide (Fig. 1a) corresponds to a 
change of the ring conformation. The radius of gyration of the ring system (Figure 1c) reveals 
further distinct transitions between differently folded ring conformations at 5.90, 6.43 and 
7.19 µs. The tail, however, fluctuates with a much higher frequency, apparently between 
two conformational states that are distributed evenly over the simulation. The video clip 
(Video S 1) suggests that these two tail states may be assigned to an extended state 
(Scheme 2a), in which the tail points away from the ring, and a folded state (Scheme 2b) in 
which the tail turns towards the lower face of the ring. The high frequency of transitions 
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between the two tail states indicates a high flexibility of the tail, significantly higher than the 
ring. 
 
DASH state analysis 
A DASH analysis of all 16 Φ/Ψ dihedral angles (T16) of the AVP backbone (C 2 to 9) during 
the 11 µs MD simulation results in 35 conformational states. Every DASH state represents, 
like a cluster, a conformation that is representative for an ensemble of similar backbone 
conformations. The 35 overall states can be clustered into four groups of states with 
common structural characteristics for the cyclic part of the peptide (Fig. 2a-d) and a fifth 
group of states (“variants”, Fig. S1 and Table S1) that does not match one of the main 
groups. This fifth group occurs between 5.90 and 6.43 µs. A detailed table of the sequence of 
DASH states (DASH state trajectory) during the 11 µs simulation is available as 
Supplementary Material (Table S2). 
DASH ring-state analysis 
As the RMSD trajectories suggest that the tail movements do not affect the main ring 
conformation, we first focused the DASH analysis on the ring dihedrals Φ/Ψ 2 to 6 (T10). 
Each DASH state now represents an ensemble of similar ring-backbone conformations 
shown in Figure 3 and Table 2. In order to distinguish between DASH overall states and DASH 
ring states, DASH overall states are denoted as T16 and DASH ring states as T10. 
The initial 35 overall states are now reduced to twelve ring states. These ring states can be 
assigned clearly to the main time-windows of the trajectory between the transitions at 1.46, 
5.90, 6.43, and 7.10 µs (Fig. 1a-c). Furthermore, analyzing the T10 and T16 DASH state 
trajectories (Fig. 4, Table S2), shows that each overall state can be assigned to a distinct ring 
state (see Table 2). In other words, each overall state can be considered as a main ring 
conformation combined with a distinct tail-conformation, as will be discussed in detail 
below. Table 2 shows absolute and relative populations of overall and ring states and how 
they correspond. Absolute populations refer to the total simulation time of 11 µs and 
relative populations refer to the individual lengths of a conformational time-window. The 
main ring conformations and the corresponding main windows are denoted as (a) open (0 to 
1.46 µs), (b) saddle (1.46 to 5.90 µs), (c) clinched open (6.43 – 7.19 µs) and (d) 
twisted saddle (7.19 to 11µs) to reflect common structural characteristics. The fifth window 
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identified on the RMSD plot between 5.90 and 6.43 µs contains variants of the main ring 
conformations and will not be discussed in detail here. This work is focused on AVP´s main 
conformational states, which correspond to the four main trajectory windows. Other, short-
lived states are observed during the simulation, but do not play a significant role and will 
only be defined in the Supporting Information. 
Populations of the conformations 
The four main ring conformations (open, saddle, clinched open and twisted saddle) are 
present for more than 95% of the simulation time. As a result of the DASH ring analysis, 
every conformational group is represented by two ring states (T10), a main state with a 
relative population of up to 94% and a less populated state. Both major and minor states are 
present for 95 to 100% of the relevant time-window. Figure 3 shows the Cα 1 to 6 alignment 
of the ring states for each main ring conformation. Frequent interconversions between the 
representative states occur within each main conformational window. The DASH state mean 
angles (Table 3, Fig. S 2) reveal that the major and minor ring-states of a distinct 
conformational group (open or saddle) differ significantly (more than 60°) for only one 
torsional angle. This is 6 for the open and saddle (differences of 72° and 66°, respectively; 
only 52° for twisted saddle and 35° for clinched open) states and Ψ5 (73°) for the clinched 
open states. The DASH state mean angles (Table 3, Fig. S2) reveal that the major and minor 
ring-states of a distinct conformational group (open or saddle) differ in only one torsion. This 
is Φ 6 for the open, saddle and twisted saddle states and Ψ 5 for the clinched open states. 
These result in different disulfide-bridge conformations for each state. Although the 
disulfide-bridge torsions were not included in the DASH ring-state analysis, their 
conformations are probably characteristic (see Fig. 3a-d, disulfide-bridges are shown as 
lines). RMSD differences between states of the same ring conformation are small, ≤ 0.25 Å, 
in comparison to RMSD differences between states of different ring conformations, 0.9 to 
2.2 Å (Table S3). The saddle and the twisted saddle ring conformations are the most 
populated structures, with absolute populations of 40 and 35%, respectively. The open 
conformations, open and clinched open, occur only 13 and 7% of the time.  
Secondary structure and hydrogen bonds 
The secondary structure was determined by means of ring-internal turn propensities, turn 
types and hydrogen bonds. Turn propensities and hydrogen-bond occupancies were 
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calculated using AMBER tools, and turn types were identified by comparing the DASH 
mean-angles with ideal β-turn type torsions. Turn propensities and hydrogen-bond 
populations are given in Table 4 and Table 5 and the torsion-angle ensembles for every main 
DASH ring state in Table 3 and the results are illustrated in Scheme 1. 
The saddle (Scheme 1b, Fig. 3b) and related twisted saddle (Scheme 1d, Fig. 3d) ring 
conformations are the most highly populated, occurring for 75% of 11 µs (Table 2). Both 
feature a highly populated (more than 90%) turn at residues Phe3 and Gln4. The saddle is 
characterized by a further turn centered at Asn5 (89%). This turn also occurs in the twisted 
saddle but is less highly populated (62%). The DASH-state mean-angles (Table 3 and S 4) 
reveal a β-turn type I centered at 3,4 for the saddle conformation in addition to a slightly 
distorted β-turn type I centered at 4,5. These β-turns are stabilized by highly populated (83-
96%) hydrogen bonds between the carbonyl-oxygen of Tyr2 (Tyr2O) and the amide-hydrogen 
of Asn5 (Asn5NH), and between Tyr2O and Cys6NH. In the twisted saddle ring-conformation, 
however, only the Tyr2O-Asn5NH hydrogen bond is highly populated (83%) and the 3,4 
centered turn is now a classical β-turn type II. The difference between a β-turn type I and 
type II is simply the orientation of the central peptide bond 3,4. The twisted saddle 
conformation shows a slight tendency to form a Tyr2NH-Asn5O hydrogen bond (7% 
occupancy). A Tyr2NH-Asn5O hydrogen bond has also been suggested on the basis of NMR 
experiments19]. A rearrangement from saddle to twisted saddle or changing the 3,4 β-turn 
from type I to type II twists the ring making it more open (cf. radius of gyration, Fig. 1c), 
whereas the main orientation of the side chains 2 to 4 remains unchanged. This may be 
necessary to facilitate AVP entry and/or fit into different GPCR pockets.  
There is no direct transition between saddle and twisted saddle in the 11 µs MD, suggesting 
that interconversion of the two ring conformations may occur via one or more 
conformational intermediates, e.g. the clinched open conformation or the variants that are 
observed between 5.90 and 6.43 µs.  
The relatively sparsely populated clinched open ring conformation (Scheme 1c, Fig. 3c) is 
significantly less folded than the two saddle conformations but more than the open. The 
most highly populated intramolecular hydrogen-bond is Phe3O-Cys6NH (28%, Table 5) and 
turns centered at Gln4 and Asn5 occur about half of the time (46%, Table 4). Loosely defined 
turns are thus more likely than ideal β-turns. The DASH ring-state mean-angles show a very 
high fluctuation of Ψ 5 (standard deviation = 61°, Table 3) so unambiguous turn-type 
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assignment is not possible. The clinched open ring structure can be classified as a flexible 
ring conformation with a tendency to form a β-turn type VIII or type I centered at 4,5. 
Finally, the open ring conformation, the starting conformation for the simulation, shows 
none of the ideal turn structures (Scheme 1a, Fig. 3a). There is a slight tendency to center 
ring turns at residues Tyr2 and Phe3 (20%, Table 5) accompanied by sparsely populated 
hydrogen bonding-interactions of Tyr2O and Gln4NH (39%), and Cys1O and Gln4NH (12%). 
Summarizing, this ring conformation can be readily classified as open as it has no 
significantly populated intramolecular hydrogen bonds and no defined β-turns. 
Transition key torsions 
A torsion angle is defined as a key torsion if its value changes significantly (> 90°) from one 
ring conformation to another. Fig. 5 shows the differences of the mean torsions for the main 
ring conformations open, saddle, clinched open and twisted saddle represented by the main 
ring states (T10, Table 2). Only dihedrals Φ 2, Φ 5 and Φ/Ψ 6 do not show large differences, 
all other torsions can be qualified as key torsions for interconversions between the main ring 
conformations. A complete list of key torsion angle differences between main ring 
conformations is given in Table S5. Direct transitions only occurred between (i) open and 
saddle and (ii) clinched open and twisted saddle. The key torsions for these transitions are 
(i) Φ 3, Ψ 4, Ψ 5 (Scheme 3a,b) and (ii) Ψ 2, Φ 4, Ψ 5 (Scheme 3c,d). Changes of these 
torsions correlate with rotations of the corresponding peptide bonds and the relative 
orientation of carbonyl oxygens and amide hydrogens, and elucidate the mechanism of 
interconversions. 
For example, to convert open to saddle, the Tyr2 carbonyl-oxygen and the amide hydrogens 
of Asn5 and Cys6 should point into the ring. Torsions Φ 3, Ψ 4 and Ψ 5 are the key torsions 
responsible for turning these atoms into the ring and thus to enable the characteristic 
intramolecular hydrogen bond to be formed. To interconvert from clinched open to twisted 
saddle, the hydrogen bond Phe3O-Cys6NH must be replaced by one between Tyr2O and 
Asn5NH. This is accomplished by rotating Ψ 2 and Φ 4, which turns Tyr2O into the ring 
displacing Phe3O. A concomitant rotation of Ψ 5 causes Cys6NH to turn thereby weakening 
the hydrogen bond between Phe3O and Cys6NH. These ring interconversions have so far 
proved too complex for their thermodynamics to be determined by simple umbrella 
sampling and are therefore now being investigated using dual-topology thermodynamic 
integration.  
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Disulfide bridge 
One remaining important feature of the ring conformations is the chiral disulfide dihedral χ 3 
(∠ Cys2Cβ-Cys2S-Cys6S-Cys6Cβ), Figure 6 shows the dynamics of this torsion. The disulfide 
bridge adopts two main conformations for χ 3 with average values of either +88.9° (g) or 
-86.6° (g’). Interconversions between these two states do not necessarily correspond to 
transitions between different time-windows of the ring conformations but are rather 
frequent independent occurrences. Each main ring conformation can exhibit conformations 
of the disulfide bridge conformations with negative and positive dihedrals. Transitions 
between these disulfide conformations occur independently of the main ring conformation. 
The positive torsion angle is favored by 78.2 to 21.8% and is consistent with experimental 
evidence (see e.g.41). The simulation suggests that g/g’ transitions are more frequent for 
open ring conformations than for saddle.  
Tail conformations 
As described above, the RMSD trajectory of the Cα 7 to 9 segment (Fig. 1d) suggests two 
equally distributed main conformations for the tail, whereas the DASH analysis of the tail 
dihedrals Φ/Ψ 7 to 9 allows these dynamic conformations to be classified in detail. The 
results are given in Table 6, Scheme 2 and Figure 7. There are six distinct tail states (T6) that 
reveal two major tail conformations, (i) an extended tail conformation with no significant 
turns, and (ii) a tail conformation with a 7,8 β-turn type II, here denoted as folded. Each 
main conformation is represented by two DASH states, differing in torsions Φ/Ψ 9 (Fig. S3). 
These torsions are only responsible for the orientation of the C-terminal CONH2-group and 
do not affect the extended or folded conformation. 
AVP favors the extended conformation of the tail significantly with an absolute population of 
81% during the simulation vs. 17% for the folded 7,8 β-turn type II conformation. The 
preference for the extended tail conformation is most likely due to the bulky residue Arg8, 
which causes steric clashes when the tail is folded. 
Two further transient conformations can be identified, a hybrid tail conformation (absolute 
population 2.0%), which is not completely extended but has no defined folding, and a 7,8 β-
turn type I structure (absolute population 0.8%). 
Figure 4 shows the DASH state trajectories for all overall states (T16), ring states (T10) and 
tail states (T6). There are 176 transitions between the six T6 tail-states but only 77 
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transitions between the twelve T10 ring-states, confirming that the tail is significantly more 
flexible than the ring. The most striking result, however, is that the tail states do not 
correlate directly with ring states in terms of transitions or formation of distinct 
conformational groups. In fact, similarly to the two states of the disulfide bridge, all tail 
states are distributed evenly over the entire simulation independently of the ring 
conformation. This is shown convincingly by a principal component analysis of the torsion 
angles throughout the simulation. As is shown in Figure 8a, there are six significant principal 
components (PCs) according to the eigenvalue-one test, of which PCs 5 and 6 have 
eigenvalues just barely larger than unity and are therefore at best marginally non-trivial. 
Figure 8b shows the weights (squared coefficients) of the contributions of the individual 
torsions to PCs 1 and 2 and Figure 8c those of PCs 3 and 4. The former are clearly localized 
on the ring and the latter on the tail. The contributions of ring torsions in PCs 3 and 4 and of 
tail fluctuations in 1 and 2 are very small. Interactive 3D-plots of the first four PCs are given 
as HTML-pages in the Supporting Material. Interestingly, these show that the two twisted 
saddle states, although very similar, are clearly separated in PC-space. This separation is 
mostly due to PC2. 
Thus, every overall state can be described in a modular manner as a combination of a ring 
and a tail state. The matrix of all main-state combinations found in this simulation is given in 
Table 7. Although the conformational changes of the ring and tail are not correlated, the 
relative populations of extended and folded tail-states vary depending on the ring 
conformation (see Table 6). The highest preference for a folded tail is found for the clinched 
open ring (26% relative population), the lowest (5%) for an open ring conformation. The 
saddle and twisted saddle ring conformations are found together with a folded tail 20 and 
15% of their occurrence, respectively. Again, the sterically demanding Arg8 residue is most 
likely responsible for these preferences; the propensity to form a folded tail depends on the 
available space. 
Conclusions 
A single long (11 s) simulation of AVP in water has revealed details of its conformational 
behavior and possible biologically active conformations. Conformational changes on the MD 
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time scale are frustratingly slow, so that, even from the long simulation, we cannot estimate 
the free-energy difference between the ring conformations from their concentrations. 
However, the conformational rearrangements are clearly fast on the NMR time scale, in 
agreement with the experimental results.  
The simulation reveals four distinct ring conformations that are essentially independent of 
the faster tail motions. The saddle and twisted saddle ring conformations exhibit β-turns 
centered at residues 3,4/4,5 as expected from experiments and are fixed by transannular 
hydrogen bonds. The alternative open and clinched open conformation do not feature 
transannular H-bridges. The saddle structure identified in the simulation corresponds closely 
to that found in crystal structure 1JK4. 
The simulation is quite consistent with Sikorska and Rodziewicz-Motowidlo’s NMR results20. 
They suggest two main conformations, both with 3,4 β II-turns. One is proposed to exhibit a 
4,5 β III’-turn and the other a type I’-turn at this position. Our simulations also reveal turns at 
3,4 and 4,5 to be dominant in aqueous solution. The 3,4 β-turn type II is found in our twisted 
saddle conformation, but only with a sparsely populated 4,5 turn; a significantly high turn 
propensity at residues 4 and 5 is found in our saddle conformation but here in combination 
with a β-turn type I at residues 3 and 4. The two studies agree well about the tail 
conformation, which we found to be approximately 80% extended. 
The open structure featured in the simulation corresponds closely to the AVP conformation 
found in the crystal structure of the trypsin complex (PDB ID: 1YF4) and features neither a 
well characterized -turn nor conserved transannular hydrogen bonds. The clinched open 
conformation identified in the simulation is apparently new and probably represents an 
intermediate minority conformation involved in inter-saddle rearrangements. 
In general, the simulation is compatible with the known experimental data, which allows us 
to be confident about its accuracy, even though it is limited to 11 s and exhibits only a few 
transitions between major rings states. Above all, the main conformations found can all be 
considered as candidates for biologically active conformations in different receptors as they 
are clearly easily accessible thermodynamically. We are now carrying out extensive 
thermodynamic integration studies to define the thermodynamics of the major 
conformations in solution.  
Technically, DASH has proven to be an extremely useful and effective analysis tool for such 
simulations. In particular its beneficial scaling helps to analyze such long simulations. The 
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finding that the movements of the ring and the tail are largely independent facilitates the 
analysis considerably.  
The conformational distribution demonstrated in this work can now serve as a basis for 
comparison with those simulated for AVP docked into receptor pockets and for extended 
simulations of NMR and circular dichroism spectra. Above all, however, MD simulations have 
proven once more to be useful, and perhaps the most powerful, tools for analyzing the 
conformational behavior of peptide hormones of comparable size to AVP. 
Acknowledgments 
This work was supported by the European project “Peptide Research Network of Excellence” 
PeReNE as part of the Interreg IVA France (Channel) – England 2007-2014 program (Interreg 
EU). We thank Jonathan Essex (University of Southampton, UK) and Ronan Bureau 
(University of Caen, France) for helpful discussions and Harald Lanig (University of Erlangen, 
Germany) for support with the simulations. Work in Erlangen was supported by the 
Deutsche Forschungsgemeinschaft as part of Graduiertenkolleg 1910 “Medicinal Chemistry 
of Selective GPCR Ligands”. 
Glossary 
abs  Absolute 
AMBER  Assisted Model Building with 
Energy Refinement 
av  Average 
AVP  8-Arginine-Vasopressin 
cl.open  Clinched Open 
DASH  Dynamics Analysis by Salt and Hudson 
DMS  Dimethyl Sulfate 
ff99sb  Force Field 1999 Stony Brooks 
g/g’  gauche/gauche’ 
GNU  General Public License 
GPCR  G-Protein Coupled Receptor 
Hbond  Hydrogen Bond 
MD  Molecular Dynamics 
NH  Amide Hydrogen  
NP  Neurophysin 
OT  Oxytocin 
PC  Principle Component 
PCA  Principle Component Analysis 
PDB  Protein Data Bank 
RadGyr Radius of Gyration 
rel  Relative  
RMSD  Root Mean Square Deviation  
SDS  Sodium Dodecyl Sulfate 
StdDev  Standard Deviation 
T10  DASH analysis of torsions Φ/Ψ 2 to 6 (10 
torsions) 
T16  DASH analysis of torsions Φ/Ψ 2 to 9 (16 
torsions) 
TIP4P-Ew Transferable Intermolecular Potential 4 Point - 
Ewald 
TM  Trans Membrane 
tw.saddle Twisted Saddle 
V2R  Vasopressin-2 receptor 
O  Carbonyl Oxygen 
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Figure and schemes 
 
 
Scheme 1  
Main conformational types of the cyclic part of 8-Arg-vasopressin (AVP) 
(a) open: no intramolecular hydrogen bonds and no classical β-turn types; (b) saddle: β-turn type I centered at 3,4/4,5 and 
stabilized by a transannular hydrogen bond from Tyr2O to Asn5NH and Cys6NH; (c) clinched open: minor propensity for β-
turns type VIII or I centered at 4,5; (d) twisted saddle: β-turn type II centered at 3,4 with hydrogen bond Tyr2O to Asn5NH 
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Scheme 2 
Main conformational types of the N-terminal tail of AVP 
(a) extended tail: no turns, no significantly populated hydrogen bonds; (b) folded tail: β-turn type II centered at residues 7 
and 8, hydrogen bond from Cys6O to Gly9NH 
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Scheme 3 
Key torsions for the interconversion of the main ring conformations of 8-Arg-vasopressin 
(a,b) interconversion open to saddle at 1.46 µs (11 µs MD); (c,d) interconversion clinched open to twisted saddle at 7.10 µs 
(11 µs MD) 
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Figure 1 
Root mean square deviations (RMSD) and radius of gyration (RadGyr) of 8-Arg-vasopressin during 11 µs MD simulation 
(reference: minimized initial MD structure, AVP1YF4). (a) RMSD of Cα-backbone atoms 1to 9 (overall); (b) RMSD of Cα-
backbone atoms 2 to 6 (ring); (c) Radius of gyration of Cα-backbone atoms 2 to 6 (ring); (d) RMSD of Cα-backbone atoms 7 
to 9 (tail). Dotted lines indicate significant changes of the RMSD/RadGyr and mark time-windows of different ring 
conformations (denoted as open, saddle, variants, clinched open and twisted saddle) 
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Fig. 2 
Main overall conformations of 8-Arg-vasopressin 
Representative states in water resulting from a DASH state analysis of backbone dihedrals Φ/Ψ 2 to 9. Absolute populations 
for every group of conformations are given in parenthesis and refer to 11 µs MD 
(a) Representatives with open ring conformation; (b) representatives with saddle ring conformation; (c) representatives 
with clinched open ring conformation; (d) representatives with twisted saddle ring conformation. Depiction: backbone = 
cartoon, side chains = lines, representatives are only labeled for the main populated state of each group. Residues are only 
labeled for each major populated state 
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Fig. 3 
Main ring conformations of 8-Arg-vasopressin 
Main representative ring states in water resulting from a DASH state analysis of backbone dihedrals Φ/Ψ 2 to 6. Absolute 
population of each state during 11µs MD are given in parenthesis 
(a) open ring states; (b) saddle ring states; (c) clinched open ring states; (d) twisted saddle ring states. Depiction: backbone = 
cartoon, sidechains = lines. Residues are only labelled for the major populated state each and the N-terminal tail is not 
shown in (a) to (d) for clarity. For illustration, a ring alignment of the backbone cartoons of the 4 main ring state 
(T10_8,1,4,6) including the tail, is shown above (a) to (d). 
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Fig. 4  
DASH state trajectories for (a) overall (T16), (b) ring (T10), and (c) tails (T6) states 
For a better understanding, the corresponding RMSD trajectories for overall (Cα 2 to 9), ring (Cα 2-6) and tail (Cα 7-9) 
alignments are shown in the background. States are numbered consecutively on the second y-axis, thus every horizontal 
line is the trajectory of a single DASH state and illustrates its individual distribution during the simulation. The transitions 
between time-windows of main ring conformations are marked with vertical dashed lines. 
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Fig. 5 
DASH state mean angles (Φ/Ψ) of the main ring conformations of 8-Arg-vasopressin open, saddle, clinched open, and 
twisted saddle represented by the main ring states T10_8, 1, 4, and 6 
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Fig. 6  
Trajectory of the disulfide-bridge torsion Cys2χ3 (∠CSSC) 
Horizontal dashed lines = average disulfide bridge torsions, vertical dashed lines = transitions between time-windows of 
main ring conformations 
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Fig. 7 
Tail conformations of 8-Arg-vasopressin 
Main representative tail states resulting from a DASH state analysis of backbone dihedrals Φ/Ψ 7 to 9. Absolute population 
are given in parenthesis. (a) extended tail conformations; (b) folded tail conformations with β-turn centered at residues 7 
and 8. Depiction: tail = sticks, ring and side chains = lines. Residues are only labeled for each major populated state. 
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Fig. 8  
Summaries of the principal component analysis of the torsion angles during the simulation 
(a) Eigenvalue plot; (b) weights of the torsion angles for principal components 1 and 2; (c) weights of the torsion angles for 
principal components 3 and 4 
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Tables 
Table 1 Average root mean square deviations (avRMSD) and average radii of gyration (avRadGyr) for significant trajectory 
time-windows and backbone Cα alignments of 8-Arg-vasopressin 
 
  trajectory time window [µs] 
  0-1.46 1.46-5.90 5.90-6.43 6.43-7.19 7.1-11.00 
 alignment open saddle variants 
clinched 
open 
twisted 
open 
avRMSD [Å] overalla 1.825 2.930 2.683 2.274 2.756 
 ringb 0.950 1.807 1.765 1.592 1.717 
 tailc 0.991 1.157 1.102 1.164 1.068 
avRadGyr [Å] ring 4.077 3.278 3.569 3.870 3.500 
aCα 1-9 alignment; bCα 1-6 alignment; cCα 7-9 alignment. (Abbreviations see glossary) 
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Table 2 Representative states of the main overall and ring conformations of 8-Arg-vasopressin 
Listed are the population and conformational characteristics of the main overall states (T16) and ring states (T10) of AVP 
(minor and transient state variants: see Table S1). Absolute populations refer to 11 µs MD (100%). Relative populations 
refer to the main time-windows of each conformational group (open, saddle, clinched open or twisted saddle). 
Characteristics of each ring conformation are given by β-turn types, turn centers, and transannular hydrogen bonds 
(Hbonds). 
 
T16 
State population 
(T16) T10 
State population 
(T10) Conformational characteristics 
State abs rel State abs rel β-turn Turn H 
 
[%] [%] 
 
[%] [%] typea center bondsb 
open (0 to 1.455 µs = 1.455 µs) 
27 8.62 64.74 8 12.40 93.75 
   28 3.25 24.60 8 
     29 0.65 4.95 8 
     30 0.75 5.70 9 0.83 6.25 
   
total 13.28 100.00 
 
13.23 100.00 
no classical 
turns 2,3 (Tyr2OGln4NH) 
saddle (1.455 to 5.900 µs = 4.445 µs) 
1 0.95 2.34 1 35.97 89.02 
   2 0.74 1.82 1 
     3 19.65 48.63 1 
     4 7.88 19.51 1 
     5 1.22 3.03 1 
     6 5.60 13.87 1 
     7 3.07 7.60 2 4.10 10.13 
   8 0.35 0.87 2 
     9 0.35 0.87 2 
     10 0.25 0.62 2 
     
total 40.06 99.15 
 
40.07 99.16 I/(I) 3,4/4,5 
Tyr2OAsn5NH, 
Tyr2OCys6NH 
clinched open (6.429 to 7.187 µs = 0.758 µs) 
12 1.87 27.18 4 4.80 69.66 (VIII) 
  13 1.41 20.45 4 
     14 1.45 20.98 4 
     15 0.23 3.30 5 2.09 30.34 I 
  16 0.89 12.93 5 
     17 0.62 8.97 5 
     18 0.43 6.20 5 
     total 6.89 100.00 
 
6.89 100.00 (VIII) /I 4,5 (Phe3OCys6NH) 
twisted saddle (7.187 to 11.000 µs = 3.813 µs) 
19 14.04 36.32 6 21.8 57.62 
   20 3.24 9.34 6 
     21 0.85 2.44 6 
     22 3.81 9.91 6 
     23 0.26 0.76 7 13.33 37.11 
   24 9.84 27.98 7 
     25 2.07 5.01 7 
     26 1 2.86 7 
     total 35.10 94.62 
 
35.13 94.73 II 3,4 Tyr2OAsn5NH 
Σtotal 95.33 
  
95.32 
    T16 = overall states defined by Φ/Ψ 2 to 9; T10 = ring states defined by Φ/Ψ 2 to 6; aparentheses indicate distorted versions of ideal β-
turn types; bHydrogen bonds in parenthesis are only populated 20-40%; (Abbreviations see glossary) 
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Table 3 DASH state mean angles (Φ/Ψ) of the main ring states (T10) of 8-Arg-vasopressin 
Torsions corresponding to β-turns are marked (dark grey = turn propensity > 80%, light grey = turn propensity 40-65%) 
 
 T10 Tyr2 Tyr2 Phe3 Phe3 Gln4 Gln4 Asn5 Asn5 Cys6 Cys6 
 state Φ Ψ Φ Ψ Φ Ψ Φ Ψ Φ Ψ 
      open      
 8 -112.54 134.53 55.31 3.41 -135.33 152.15 -75.09 124.68 -127.16 148.39 
 StdDev 37.81 18.46 9.08 31.34 23.92 18.2 18.32 32.08 31.88 23.33 
 9 -98.98 129.37 56.09 0.76 -135.73 153.49 -66.41 113.78 -55.29 126.93 
 StdDev 54.64 26.48 9.27 31.72 23.88 23.1 31.29 80.23 61.52 40.84 
saddle 
 1 -80.2 143.87 -62.88 -21.36 -86.73 -7.38 -113.37 -27.13 -126.42 133.12 
 StdDev 20.52 12.37 9.44 13.4 17.2 16.94 21.14 22.14 20.16 33.23 
 2 -84.29 147.09 -57.99 -27.01 -85.13 -7.63 -122.03 -6.72 -60.49 142.38 
 StdDev 23.05 13.93 10.95 15.59 17.53 16.62 20.55 41.47 32.18 24.51 
clinched open 
 4 -95.37 -19 -101.27 156.57 -67.65 -19.06 -112.46 86.89 -117.42 145.84 
 StdDev 28.15 22.75 29.46 14.56 16.85 23.84 28.66 61.3 36.21 21.54 
 5 -90.52 -18.35 -116.2 151.18 -68.06 -20.5 -88.17 14.01 -82.72 144.88 
 StdDev 28.3 18.64 30.65 13.16 22.02 26.74 20.39 33.03 29.6 16.17 
twisted saddle 
 6 -86.02 162.33 -52.48 127.66 55.04 12.34 -107.29 -7.44 -122.17 144.18 
 StdDev 29.44 13.88 16.16 14.69 9.01 21.14 29.86 48.29 28.23 23.53 
 7 -115.65 174.87 -52.78 129.79 57.39 8.38 -114.1 -16.45 -70.67 148.3 
 StdDev 24.26 19.63 19 13.91 8.24 20.56 25.07 29.84 19.33 13.72 
Ideal Φ/Ψ (i+1, i+2): β-turn type I (-60°, -30°, -90°, 0°), type II (-60°, +120°, +80°, 0°), type VIII (-60°, -30°, -120°, 120°)42. StdDev= standard deviation 
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Table 4  Turn propensities [%] for the main ring conformations of 8-Arg-vasopressin 
 
Turn center Main ring conformation / Trajectory time-window 
residue open saddle clinched open twisted saddle 
Cys1 0.00 0.00 0.00 0.00 
Tyr2 20.20 0.00 0.00 0.18 
Phe3 20.20 94.10 0.03 90.57 
Gln4 0.08 93.93 46.28 93.80 
Asn5 0.07 89.33 46.28 61.93 
Cys6 0.00 2.53 0.00 0.01 
Pro7 3.80 18.57 20.99 10.82 
Arg8 3.80 17.32 20.99 10.82 
Gly9 0.00 0.00 0.00 0.00 
(Abbreviations see glossary) 
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Table 5  Occupancies of intramolecular hydrogen bonds [%] and corresponding turn centers for the main ring 
conformations of 8-Arg-vasopressin 
 
H-bond Main ring conformation / Trajectory time-window Turn center 
O… …HN open saddle cl.open tw.saddle residues 
Cys1 Gln4 12.03 0.00 0.00 2.24 2, 3 
Tyr2 Asn5 0.00 95.70 0.00 82.60 3, 4 
Tyr2 Cys6 0.00 83.19 0.00 37.28 3, 4, 5 
Tyr2 Gln4 38.57 2.04 0.01 0.02 3 
Phe3 Cys6 0.00 4.86 27.93 0.04 4, 5 
Phe3 Asn5 0.13 2.41 10.21 23.83 4 
Gln4 Cys6 8.78 0.06 18.67 1.60 5 
Asn5 Tyr2 0.00 0.22 0.00 6.59 3, 4 
Cys6 Gly9 2.20 10.82 12.11 5.67 7, 8 
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Table 6  Population and distribution of tail conformations 
The first column contains the DASH states (T6) that represent the tail conformations of 8-Arg-vasopressin during 11 µs MD 
simulation. Absolute populations refer to the total simulation time of 11 µs. Relative populations refer to the time-windows 
of the main ring conformation (open, saddle, clinched open, and twisted saddle). 
 
 
T6 Tail state population (T6) 
state  open saddle clinched open twisted saddle 
 (0-11.0 µs) (0-1.46 µs) (1.46-5.90 µs) (6.43-7.19 µs) (7.19-11.00 µs) 
 
abs [%] rel [%] rel [%] rel [%] rel [%] 
extended 
3 61.44 69.22 56.02 37.99 68.34 
4 19.59 24.39 20.32 30.35 15.10 
total 81.03 93.61 76.34 68.34 83.44 
7,8 β-turn type II 
5 2.52 0.00 3.87 0.00 2.75 
6 13.61 4.91 15.31 26.12 12.51 
total 16.13 4.91 19.18 26.12 15.26 
7,8 β-turn type I 
2 0.83 0.00 1.82 0.00 0.28 
distorted turn 
1 2.00 1.48 2.66 5.54 1.02 
Σtotal 100.00 100.00 100.00 100.00 100.00 
T6 = tail states defined by Φ/Ψ 7 to 9. (Abbreviations, see glossary) 
 
Conformation and dynamics of 8-Arg-vasopressin in solution (accepted author manuscript/ post-print) 
34 
 
Table 7  Overall State = Ring State + Tail State 
A matrix of overall states (T16) as combination of the ring and tail states (T10 and T6) that represent the main ring and tail 
conformations (open, saddle, clinched open, twisted saddle, extended, and folded). The states result from DASH analyses of 
torsions Φ/Ψ 2 to 9 (T16, overall states), 2 to 6 (T10, ring states) and 7 to 9 (T6, tail states). The assignment is based on the 
corresponding DASH state trajectories. PDBs of all states are provided in the Supplementary Material. 
 
Overall states (T16) 
(T6 X T10) 
Tail states (T6) 
extended 7,8 β-turn II 
61.4% 19.6% 13.6% 2.5% 
3 4 6 5 
R
in
g 
st
at
e
s 
(T
1
0
) 
open 
 
12.4% 8 27 28 29  
0.8% 9 30 28   
saddle 
 
36.0% 1 3 4 6 5 
4.1% 2 7 8 10 9 
clinched open 
4.8% 4 12 13 14  
2.1% 5 16 17 18  
twisted saddle 
21.8% 6 19 20 22 21 
13.3% 7 24 25 26  
 
 
 
 
